sa国际传媒

Trials

  • July 07, 2025

    Fed. Circ. Affirms Cisco's Defeat Of $371M Patent Suit

    The Federal Circuit on Monday declined to revive software company Egenera's $371 million patent lawsuit against Cisco, affirming lower court findings that the communications giant didn't infringe.

  • July 07, 2025

    Catching Up With Delaware's Chancery Court

    In Delaware in the past week, a vice chancellor awarded just $1 in damages to a China-tied company looking to secure a $50 million stake in SpaceX while also slamming the fund's manager for acting "insincerely," Tyson Foods won $55 million in damages in a suit claiming the owner of two poultry rendering plants Tyson acquired hid that it relied on a "disfavored" practice of recovering "unappetizing remnants of butchered chickens," and a suit over a one-site bank's 11-aircraft fleet was moved into the discovery phase.

  • July 07, 2025

    J&J Unit Looks To Wipe Out $442M Catheter Antitrust Loss

    Johnson & Johnson health tech unit Biosense Webster has asked a California federal court to throw out Innovative Health's $442 million trial win in a case accusing Biosense of conditioning product support for its cardiac mapping systems on the purchase of cardiac catheters.

  • July 07, 2025

    Feds Cite National Security As Trial Over Student Visas Begins

    A Trump administration lawyer told a Massachusetts federal judge Monday that the government's decision to revoke the visas of聽hundreds of college students and faculty over their聽pro-Palestinian speech was not viewpoint discrimination but a response to what it contends are threats to national security.

  • July 03, 2025

    Fla. Court Says Double Gun Charge Violates Jeopardy Rule

    A Florida state appeals court panel on Thursday ruled that a man convicted on two counts of being a felon in possession of firearms and ammunition can have the lesser charge dropped after the panel found it violated double jeopardy rules.

  • July 03, 2025

    Stewart Drops Mixed Bag Of Discretionary Denial Rulings

    Acting U.S. Patent and Trademark Office Director Coke Morgan Stewart has released 24 more discretionary denial decisions, more than half of which she cleared challenges to move forward through the Patent Trial and Appeal Board process.

  • July 03, 2025

    Truck Crash Case Settles Amid Appeal Of $14M Verdict

    Texas trucking companies and an injured driver have settled a nearly decade-old negligence lawsuit, ending a case that initially resulted in an $80 million verdict 鈥 later reduced to $13.7 million 鈥斅燽ut was dramatically reshaped by intervention by the state's highest court.聽

  • July 03, 2025

    Genentech's $122M MS Drug Royalties Case Ends In Mistrial

    A California federal judge declared a mistrial Thursday after jurors reached an impasse in Genentech Inc.'s $122 million breach of contract case over patent royalties from sales of Biogen MA Inc.'s multiple sclerosis medicine, telling the parties she's open to Genentech's suggestion that they forgo a jury for the retrial.

  • July 03, 2025

    SPEX To Appeal $553M Patent Verdict That Was Cut To $1

    SPEX Technologies Inc. will appeal a federal judge's decision to cut its $553 million verdict against Western Digital for data security patent infringement to $1 along with all other adverse rulings in the case.

  • July 03, 2025

    Fla. Court Rejects Oral Pact Cutting Loan Interest To 7%

    A Florida state appeals court has sided with a Nevada-based lender, reversing an oral agreement to reduce interest on a $2.6 million loan from 25% to 7%, saying such agreements must be in writing.

  • July 03, 2025

    Pa. School District Fights $2.7M Fee Bid After $165K Verdict

    The Central Bucks School District in Pennsylvania says counsel representing two female teachers awarded $165,000 in an equal pay lawsuit should not be given $2.7 million in fees, arguing that request is not proportionate to the result.

  • July 03, 2025

    Circuit-By-Circuit Recap: Justices Send Message To Outliers

    It was a tough term at the U.S. Supreme Court for two very different circuits 鈥 one solidly liberal, one solidly conservative 鈥 that had聽their rulings overturned in eye-popping numbers. But it was another impressive year for a relatively moderate circuit that appears聽increasingly simpatico with the high court.

  • July 03, 2025

    The Moments That Shaped The Universal Injunction Case

    The U.S. Supreme Court voted along ideological lines when it hindered the ability of federal district court judges to issue nationwide pauses on presidential policies, but that outcome didn't seem like a foregone conclusion during oral arguments earlier this year.聽What do the colloquies suggest about the justices' thinking? Here are some moments that may have swayed them.

  • July 03, 2025

    Pa. Judge's COVID Fraud Charges Survive Dismissal Bid

    A Pennsylvania state judge accused of misusing COVID-19 unemployment relief money to pay his law firm's staff has lost a bid to shake the criminal charges he's facing, as a federal judge rejected the state judge's argument that prosecutors withheld his ex-workers' employment records that聽he sought to determine their credibility.

  • July 03, 2025

    Free-Speech Suit Will Be Early Trial Court Test Of Trump Admin

    A Massachusetts federal judge will begin hearing testimony Monday in a challenge by academic organizations to the Trump administration's visa revocations and removals of noncitizen faculty and students who have expressed pro-Palestinian views, in one of the first trials over the president's second-term policies.

  • July 03, 2025

    What To Watch In Mass. Courts In The Second Half Of 2025

    Massachusetts courts should be busy through the second half of 2025, with litigation against the Trump administration playing a starring role at both the state and federal level. Here are some of the key cases and issues that attorneys are monitoring.

  • July 03, 2025

    The Firms That Won Big At The Supreme Court

    The number of law firms juggling three or more arguments before the U.S. Supreme Court this past term nearly doubled from the number of firms that could make that claim last term.

  • July 03, 2025

    Breaking Down The Vote: The High Court Term In Review

    The U.S. Supreme Court once again waited until the term's closing weeks 鈥 and even hours 鈥 to issue some of its most anticipated and divided decisions.

  • July 03, 2025

    The Biggest Rulings From Mass. High Court So Far In 2025

    Massachusetts' top court has tackled a controversial housing initiative, the thorny issue of qualified immunity for public employees and even a high-profile murder case in the first six months of 2025.

  • July 02, 2025

    NCAA, NASCAR Antitrust Challenges Permeate 2025's 1st Half

    The first half of 2025 saw the dispute between NASCAR and two of its teams become supercharged and a judge give final approval to the disputed settlement for the NCAA name, image and likeness antitrust litigation.

  • July 02, 2025

    The Biggest Patent Rulings Of 2025: A Midyear Report

    A ruling by the full Federal Circuit invited greater scrutiny of patent damages testimony, and the U.S. Patent and Trademark Office's acting director established new criteria for rejecting patent challenges. Here's a look at the top patent decisions from the first half of 2025.

  • July 02, 2025

    Pentegra Agrees To Pay $48.5M After $38.8M ERISA Verdict

    A New York federal judge Wednesday preliminarily approved a settlement in which Pentegra Retirement Services agreed to pay nearly $10 million more than a $38.8 million jury verdict awarded to a 27,000-member class of 401(k) plan participants who challenged the plan's excessive administrative fees.

  • July 02, 2025

    Girardi Asks To Remain Free During Fraud Appeal

    Disbarred attorney Tom Girardi asked a California federal judge on Wednesday to remain free on bond while he appeals his wire fraud conviction, saying he's not a flight risk or danger to the community and there are several issues on appeal that could result in reversal or resentencing.

  • July 02, 2025

    Genentech's $122M IP Fight Against Biogen In Jury's Hands

    Genentech Inc. wrapped a California federal trial Wednesday over claims that Biogen MA Inc. wrongly withheld $122 million in royalties for supplies of Biogen's multiple sclerosis drug, reminding jurors that Biogen's own internal projections showed it owing royalty payments in the years after the main patent expired in December 2018.

  • July 02, 2025

    Judge Revives Supplement Patent Claims Jury Found Invalid

    A Delaware federal judge Wednesday allowed HQ Specialty Pharma Corp. to correct an injectable calcium supplement patent it accused Fresenius Kabi of infringing and found the claims were no longer invalid as a result.

Expert Analysis

  • Series

    Law School's Missed Lessons: Mastering Discovery

    Author Photo

    The discovery process and the rules that govern it are often absent from law school curricula, but developing a solid grasp of the particulars can give any new attorney a leg up in their practice, says Jordan Davies at Knowles Gallant.

  • Strategies To Limit Inherent Damage Of Multidefendant Trials

    Author Photo

    As shown by the recent fraud convictions of two executives at the now-shuttered education startup Frank, multidefendant criminal trials pose unique obstacles, but with some planning, defense counsel can mitigate the harm and maximize the chances of a good outcome, says Kenneth Notter at MoloLamken.

  • Series

    Playing Guitar Makes Me A Better Lawyer

    Author Photo

    Being a lawyer not only requires logic and hard work, but also belief, emotion, situational awareness and lots of natural energy 鈥 playing guitar enhances all of these qualities, increasing my capacity to do my best work, says Kosta Stojilkovic at Wilkinson Stekloff.

  • Crisis Management Lessons From The Parenting Playbook

    Author Photo

    The parenting skills we use to help our kids through challenges 鈥 like rehearsing for stressful situations, modeling confidence and taking time to reset our emotions 鈥 can also teach us the fundamentals of leading clients through a corporate crisis, say Deborah Solmor at the Wisconsin Alumni Research Foundation and Cara Peterman at Alston & Bird.

  • 4 Ways To Leverage A Jury's Underdog Perceptions

    Author Photo

    Counsel should consider how common factors that speak to their client's size, power, past challenges and alignment with jurors can be presented to try and paint their client as a sympathetic underdog, says Ken Broda-Bahm at Persuasion Strategies.

  • Why Hiring Former Jurors As Consultants Can Be Risky

    Author Photo

    The defense team's decision to hire former juror Victoria George in the high-profile retrial of Karen Read shines a spotlight on this controversial strategy, which raises important legal, ethical and tactical questions despite not being explicitly prohibited, says Nikoleta Despodova at ND Litigation.

  • Series

    Adapting To Private Practice: From NY Fed To BigLaw

    Author Photo

    While the move to private practice brings a learning curve, it also brings chances to learn new skills and grow your network, requiring a clear understanding of how your skills can complement and contribute to a firm's existing practice, and where you can add new value, says Meghann Donahue at Covington.

  • Combs Case Reveals Key Pretrial Scheduling Strategies

    Author Photo

    The procedural battles over pretrial disclosure deadlines leading up to the criminal trial of Sean 鈥淒iddy鈥 Combs show how disclosure timing can substantially affect defendants鈥 ability to prepare and highlight several scheduling pointers for defense counsel, says Sara Kropf at Kropf Moseley.

  • Top 3 Litigation Finance Deal-Killers, And How To Avoid Them

    Author Photo

    Like all transactions, litigation finance deals can sometimes collapse, but understanding the most common reasons for failure, including a lack of trust or a misunderstanding of deal terms, can help both parties avoid problems, say Rebecca Berrebi at Avenue 33 and Boris Ziser at Schulte Roth.

  • 5th Circ. Ruling Is Latest Signal Of Shaky Qui Tam Landscape

    Author Photo

    In his recent concurring opinion in U.S. v. Peripheral Vascular Associates, a Fifth Circuit judge joined a growing list of jurists suggesting that the False Claims Act's whistleblower provisions are unconstitutional, underscoring that acceptance of qui tam relators can no longer be taken for granted, say attorneys at Miller & Chevalier.

  • How Attys Can Use A Therapy Model To Help Triggered Clients

    Author Photo

    Attorneys can lean on key principles from a psychotherapeutic paradigm known as the "Internal Family Systems" model to help manage triggered clients and get settlement negotiations back on track, says Jennifer Gibbs at Zelle.

  • How Attorneys Can Make The Most Of A Deposition Transcript

    Author Photo

    With recent amendments to federal evidence rules now in effect, it鈥檚 more important than ever to make sure that deposition transcripts are clear and precise, and a few key strategies can help attorneys get the most out of a transcript before, during and after a deposition, says Allison Rocker at Baker McKenzie.

  • 3 Steps For In-House Counsel To Assess Litigation Claims

    Author Photo

    Before a potential economic downturn, in-house attorneys should investigate whether their company is sitting on hidden litigation claims that could unlock large recoveries to help the business withstand tough times, says Will Burgess at Hilgers Graben.

  • Series

    Teaching College Students Makes Me A Better Lawyer

    Author Photo

    Serving as an adjunct college professor has taught me the importance of building rapport, communicating effectively, and persuading individuals to critically analyze the difference between what they think and what they know 鈥 principles that have helped to improve my practice of law, says Sheria Clarke聽at聽Nelson Mullins.

  • A New Tool For Assessing Kickback Risks In Health Marketing

    Author Photo

    The Seventh Circuit's recent decision in U.S. v. Sorensen, reversing a conviction after trial of a durable medical equipment distributor, highlights two principle considerations for determining whether payments to marketers in healthcare are unlawful under the Anti-Kickback Statute, says Elisha Kobre at Sheppard Mullin.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Trials archive.